NTRA

Natera (NTRA)

About Natera (NTRA)

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Details

Daily high
$229.22
Daily low
$225.80
Price at open
$227.81
52 Week High
$246.90
52 Week Low
$125.38
Market cap
31.6B
Dividend yield
0.00%
Volume
898,294
Avg. volume
1.6M
P/E ratio
-99.99

Natera News

Details

Daily high
$229.22
Daily low
$225.80
Price at open
$227.81
52 Week High
$246.90
52 Week Low
$125.38
Market cap
31.6B
Dividend yield
0.00%
Volume
898,294
Avg. volume
1.6M
P/E ratio
-99.99